Multiple Myeloma Stories

Plus Newest Treatment Updates

Explore below for in-depth multiple myeloma stories from our patients who share everything from first symptoms to navigating life with cancer.

Also read our in-depth interviews with experienced myeloma experts who talk about the newest treatment for multiple myeloma.

Table Of Contents

Multiple Myeloma Basics
Stories by Type
- Active Myeloma
- Inactive Myeloma
  - Smoldering Myeloma
Stories by Treatment
- 1st Line Treatment
- Relapsed/Refractory Treatment
Multiple Myeloma Specialist Interviews
New Series: Newest Treatment for Multiple Myeloma

Multiple Myeloma Basics

“Multiple myeloma belongs to the group of diseases we think about when we think about blood cancers. Specifically, myeloma is a form of adult bone marrow cancer that comes about when plasma cells convert into malignant cells,” says Dr. Rafael Fonseca of Mayo Clinic.

Multiple myeloma is a rare form of cancer that occurs in the plasma cells. Read real experts talk about what myeloma is, its diagnosis and treatment options including new CAR-T cell therapy, proteasome inhibitors and more. ...

Stories by Type

Explore our multiple myeloma stories below, where patients describe things like:

First myeloma symptoms
What treatments they underwent
Living with multiple myeloma

Active Myeloma

Clay D.

Diagnosis: Multiple myeloma
1st Symptoms: Persistent kidney issues, nausea
Treatment: chemo, radiation, stem cell transplant
...

Melissa V.

Diagnosis: Multiple myeloma, stage 3
1st Symptoms: Frequent infections
Treatment: IVF treatment & Chemotherapy (RVD) for 7 rounds
...

Elise D.

Diagnosis:Multiple myeloma, refractory
1st Symptoms:Lower back pain, fractured sacrum
Treatment: CyBorD, Clinical trial of Xpovio (selinexor)+ Kyprolis (carfilzomib) + dexamethasone
...

Typical Myeloma

The majority of people diagnosed with myeloma fall under this category:

IgG k (kappa)
IgG λ (lambda)
IgA k (kappa)
IgA λ (lambda)

Scott C.

Diagnosis: Multiple myeloma, relapsed/refractorySubtype:IgG lambda (majorityof myelomas)
1st Symptoms: Pain in hips and ribs, night sweats, weight loss, nausea
Treatment: Clinical trial, chemo, kyphoplasty, stem cell transplant

Jude A.

Diagnosis: Multiple myeloma, stage 3
1st Symptoms: Pain in back, hips and ribs; difficulty walking
Treatment: Bilateral femoral osteotomy, reversal due to infection; chemotherapy

Light Chain Myeloma

It’s estimated that light chain myeloma makes up about 15% of all myeloma diagnoses. There are times when malignant plasma cells produce only the light chain component of the antibody. Patients diagnosed with these cases have what’s known as “light chain myeloma.”

Carlos C.

Diagnosis: Multiple myeloma, Light Chain, Stage 2
1st Symptoms: Back pain and spasms
Treatment: Back surgery to fuse T1 and T2, chemotherapy (RVD) and stem cell transplant

Non-secretory myeloma

Beth A.

Diagnosis:Multiple myeloma, relapsed/refractory
Subtype: Non-secretory (1-5% of myelomas)
1st Symptoms:Extreme pain between shoulder blades, sternum, head, burning sensation
1st Line Treatment:VAD chemo, radiation, stem cell transplant
RR Treatment: 8 chemo regimens, successful combo→selinexor+bortezomib+dexamethasone

Inactive Myeloma

Smoldering Myeloma

Maui B.

Diagnosis: Smoldering myeloma
Cancer Details: Smoldering myeloma is pre-symptomatic or pre-treatment multiple myeloma
1st Symptoms: Inflammatory eye disease, uterine bleeding
Treatment: N/A
...

Stories by Treatment

1st Line Treatment

Melissa V.

Diagnosis: Multiple myeloma, stage 3
1st Symptoms: Frequent infections
Treatment: IVF treatment & Chemotherapy (RVD) for 7 rounds

Jude A.

Diagnosis: Multiple myeloma, stage 3
1st Symptoms: Pain in back, hips and ribs; difficulty walking
Treatment: Bilateral femoral osteotomy, reversal due to infection; chemotherapy

Relapsed/Refractory Treatment

Donna K.

Diagnosis:Multiple myeloma, refractory
1st Symptoms:None, found by blood tests
Treatment: Total Therapy Four, carfilzomib+pomalidomide, daratumumab+lenalidomide, CAR T, selinexor-carfilzomib

Connie H.

Diagnosis: Multiple myeloma, relapsed refractory
1st Symptoms: Chronic bone pain
Treatment: IV Chemotherapy, CAR T cell therapy

Multiple Myeloma Specialist Interviews

Hear directly from experienced myeloma oncologists and specialists. They talk about multiple myeloma in layman’s terms, describe the latest myeloma treatments, and what patients should be asking their doctors.

New Series: Newest Treatment for Multiple Myeloma

Top myeloma specialist, Dr. Rafael Fonseca of Mayo Clinic, sits down with The Patient Story for a deep dive into the landscape of treatment for multiple myeloma, from first line treatment to relapsed/refractory treatment, emerging T-cell therapies, and the importance of clinical trials.

Read more →

James Berenson, MD

Oncologist: Specializing in myeloma and other blood and bone disorders
Experience: 35+ years
Institution: Berenson Cancer Center

Irene Ghobrial, MD

Role: Clinical investigator and professor of hematological oncology
Focus: Multiple myeloma, Waldenström’s Macroglobulinemia, early screening, clinical trials
Provider:Dana-Farber Cancer Institute (Boston)

Nina Shah, MD

Role: Hematologist-oncologist, researcher
Focus: Multiple Myeloma
Institution: University of California, San Francisco (UCSF)

Rafael Fonseca, MD

Role: Interim executive director, hematologist-oncologist
Focus: Multiple myeloma, new drug development
Institution: Mayo Clinic

CAR T Cell Therapy in Myeloma

Dr. Fonseca shares his insights on emerging T-cell therapies for multiple myeloma, describing the role T-cells play in our bodies and then focusing on chimeric antigen receptor (CAR) T-cell therapy and bispecific T-cell engagers.

How Do Clinical Trials Work?

In this episode, Dr. Fonseca details the process of clinical trials, as well as how patients and families can better understand what goes on during each of the main parts of the study.

Joseph Mikhael, MD

Role: Dir. Myeloma Research, CMO at International Myeloma Foundation (IMF)
Focus: Multiple myeloma
Provider: TGen/City of Hope